84% of US dentists are independent. AI recall works there too.

"AI recall is built for the big groups. A multi-site DSO has the patient volume and the IT budget to make it worth the investment. A two-dentist independent practice doesn't." That is roughly how the objection lands whenever AI-driven patient recall comes up among practice owners weighing whether to add a third location. It sounds like a reasonable read of the market. It is also wrong, and the ADA's own data proves it in a single number.

84%. That is the share of US dentists who were not affiliated with a dental service organisation in 2024, according to the American Dental Association's Health Policy Institute, cited via Becker's Dental Review (August 2025). DSO affiliation reached 16.1% that year, up from 7.2% in 2015, an 8.9 percentage point rise over a decade. That is real growth. It is nowhere close to making DSOs the default model. Four out of five practising dentists in the country still run independent or small-group operations. If AI recall tools genuinely only worked at DSO scale, the companies selling them would be ignoring 84% of their own addressable market. They are not, and the economics explain why.

Who the market actually is

The DSO growth story gets a lot of coverage because it is the more dramatic one: private equity-backed groups, multi-state rollups, aggressive acquisition targets. That coverage creates an impression that independent practice is a shrinking, legacy category being serviced by legacy tools. The ADA HPI numbers do not support that. Younger dentists are affiliating with DSOs at a higher rate (roughly 1 in 4 among those under 10 years post-graduation), but the overall market remains overwhelmingly independent, and the shift from 7.2% to 16.1% over nine years is gradual, not a stampede.

For a practice owner running one or two sites, the practical implication is that recall software vendors have every commercial incentive to build for you specifically, not to treat you as a scaled-down version of a DSO product. So what this means for your practice: if a vendor's pitch leans heavily on "enterprise" or "multi-location standardisation" language, that is a signal about their target customer, not proof that smaller independent practices are outside the addressable market for the underlying technology.

The no-show math does not need multiple locations

The economic case for AI recall rests on the cost of no-shows, and that cost exists identically whether a practice has one chair or fifty. Planet DDS's 2025 industry benchmarks, drawn from 3,400 US dental practices, put the confirmed no-show rate at 7.4% of scheduled appointments. At an average production of $475 to $575 per dentist hour (ADA Survey of Dental Practice, 2024), a single general practice running a standard schedule can lose well over $100,000 a year in production to no-shows alone, before accounting for the additional 15.5% of appointments cancelled in advance.

Industry benchmark data across multiple reminder-system deployments in 2025 shows a 23% to 38% reduction in no-shows when practices move from manual to automated, AI-assisted reminder sequences, compared with manual reminders. That range does not scale with location count. A single-site practice recovers the same percentage of its own no-show baseline that a ten-site group recovers across its combined baseline. What does scale with location count is the coordination problem: research and industry data consistently show that 60% to 70% of no-shows are generated by 15% to 20% of the patient base, and at a single site, front-desk staff often already know who those patients are informally. That informal knowledge is exactly what breaks down at multi-site scale, which is one of the reasons DSOs need software to replace what a solo or two-site practice can partly do through staff memory.

So what this means for your practice: the dollar case for AI recall stands on your own site's numbers. You do not need a second or third location to make the return on investment work, and in one specific respect, a smaller practice's existing informal recall knowledge means the software has less ground to make up.

Where DSO scale becomes a disadvantage

There is a structural argument, not just an economic one, for why DSO scale slows AI adoption rather than accelerating it. In April 2026, Heartland Dental, the largest DSO in the US, announced a phased rollout of DentalXChange's Eligibility AI and PortalPass credential management tools across its network of more than 1,900 supported locations in 38 states (BusinessWire, via Oral Health Group, April 2026). The rollout is enterprise-scale integration work: coordinating deployment, training, and system compatibility across nearly two thousand sites that were built up through acquisition and therefore run on a mix of legacy systems.

Some industry commentators go further, arguing that DSOs face an "AI fragmentation problem," where a different vendor handles each function (clinical documentation, eligibility, claims, patient communication) with no shared data layer, and every integration gap multiplies across every acquired location. That framing comes from a company selling unified practice management software to both independent and DSO customers, so treat it as informed but self-interested rather than neutral. The underlying pattern, enterprise AI rollouts needing months of standardisation before a single location goes live, is independently visible in how Heartland's own deployment was structured.

An independent practice, or a two-site group evaluating a third, does not carry that integration burden. One practice management system, one patient record, one team to train. So what this means for your practice: a recall platform that would take a DSO a multi-month enterprise rollout to standardise can typically go live at a single or two-site independent practice in four to six weeks, from contract to full deployment.

What the vendors actually build

The clearest evidence against the DSO-only myth is what the recall software market actually sells. MaxAssist (formerly RecallMax) markets its automated recall and scheduling tools explicitly to "solo practices, groups, and DSOs" as three separate customer segments, not a single enterprise tier (MaxAssist product pages, 2026, vendor-published). NexHealth's published customer data claims practices seeing 15 or more new patients a week, a volume well within reach of a busy single-site practice, can recover 2 to 4 hours of front-desk time daily through its scheduling automation (NexHealth customer case studies, 2025, vendor-reported case study, not independently verified). Weave and Lighthouse 360, the two other platforms most commonly evaluated by US dental groups in the $1 to $3 million annual production range, price per location rather than per enterprise contract, which only makes commercial sense if a meaningful share of their customer base is running one or two sites.

None of these figures should be taken as endorsements. Vendor-reported case studies describe best-case outcomes, and pricing structures change. What they demonstrate reliably is intent: the companies building AI recall tools are not designing exclusively for DSO procurement teams. So what this means for your practice: the products exist, they are priced for your scale, and evaluating one does not require pretending to be a bigger organisation than you are.

The call

If you are running one or two dental sites and have held off on AI recall because it felt like a DSO-tier investment, the evidence points the other way. Run your own no-show number first: take your confirmed no-show rate over the last three months, multiply it by your average production per appointment, and compare that figure against the $300 to $600 a month that most recall platforms charge per location. For the overwhelming majority of independent practices, that comparison favours adoption well before location count becomes relevant.

Before signing with any recall vendor, confirm they will provide a signed HIPAA Business Associate Agreement covering the tool's handling of patient contact data. Any platform that cannot produce one on request is not appropriate for use in a clinical setting, regardless of practice size.

For a scored, independent look at where AI recall fits alongside scheduling, billing, and front-desk automation in your specific practice, the AI Opportunity and Growth Assessment covers all four in a single report. Start with a free 20-minute discovery call.

See also: the full no-show revenue calculation and tool comparison for dental groups and the 5 questions every dental practice owner should ask before buying any AI tool.

Related: Dental practices lose $140K a year to no-shows. AI recall data shows how much is recoverable. · The 5 questions every dental practice owner should ask before buying any AI tool · CQC dental well-led: 10% failure rate. What AI adds in 2026